Literature DB >> 8471029

4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).

K Saito1, C Y Chen, M Masana, J S Crowley, S P Markey, M P Heyes.   

Abstract

Accumulation of quinolinic acid and L-kynurenine occurs in the brain and/or blood following immune activation, and may derive from L-tryptophan following induction of indoleamine 2,3-dioxygenase and other kynurenine-pathway enzymes. In the present study a survey of various cell lines derived from either brain or systemic tissues showed that, while all cells examined responded to interferon-gamma by increased conversion of L-[13C6]tryptophan into L-kynurenine (human: B-lymphocytes, neuroblastoma, glioblastoma, lung, liver, kidney; rat brain: microglia, astrocytes and oligodendrocytes), only macrophage-derived cells (peripheral-blood mononuclear cells; THP-1, U-937) and certain liver cells (SKHep1) synthesized [13C6]quinolinic acid. Tumour necrosis factor-alpha enhanced the effects of interferon-gamma in THP-1 cells. Norharmane, 6-chloro-DL-tryptophan and 4-chloro-3-hydroxyanthranilate attenuated quinolinic acid formation by THP-1 cells with IC50 values of 51 microM, 58 microM and 0.11 microM respectively. Norharmane and 6-chloro-DL-tryptophan attenuated L-kynurenine formation with IC50 values of 43 microM and 51 microM respectively, whereas 4-chloro-3-hydroxyanthranilate had no effect on L-kynurenine accumulation. The reductions in L-kynurenine and quinolinic acid formation are consistent with the reports that norharmane is an inhibitor of indoleamine 2,3-dioxygenase, 6-chloro-DL-tryptophan is metabolized through the kynurenine pathway, and 4-chloro-3-hydroxyanthranilate is an inhibitor of 3-hydroxyanthranilate 3,4-dioxygenase. These results suggest that many tissues may contribute to the production of L-kynurenine following indoleamine 2,3-dioxygenase induction and immune activation. Quinolinic acid may be directly synthesized from L-tryptophan in both macrophages and certain types of liver cells, although uptake of quinolinic acid precursors from blood may contribute to quinolinic acid synthesis in cells that cannot convert L-kynurenine into quinolinic acid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471029      PMCID: PMC1132472          DOI: 10.1042/bj2910011

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims.

Authors:  R Schwarcz; E Okuno; R J White; E D Bird; W O Whetsell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 2.  Quinolinic acid and other kynurenines in the central nervous system.

Authors:  T W Stone; J H Connick
Journal:  Neuroscience       Date:  1985-07       Impact factor: 3.590

Review 3.  Biochemistry of tryptophan in health and disease.

Authors:  D A Bender
Journal:  Mol Aspects Med       Date:  1983

4.  Characteristics of interferon induced tryptophan metabolism in human cells in vitro.

Authors:  G Werner-Felmayer; E R Werner; D Fuchs; A Hausen; G Reibnegger; H Wachter
Journal:  Biochim Biophys Acta       Date:  1989-07-11

5.  Inhibition of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by beta-carboline and indole derivatives.

Authors:  N Eguchi; Y Watanabe; K Kawanishi; Y Hashimoto; O Hayaishi
Journal:  Arch Biochem Biophys       Date:  1984-08-01       Impact factor: 4.013

6.  Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography.

Authors:  E W Holmes
Journal:  Anal Biochem       Date:  1988-08-01       Impact factor: 3.365

7.  Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

Authors:  K Saito; S P Markey; M P Heyes
Journal:  Neuroscience       Date:  1992-11       Impact factor: 3.590

8.  Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.

Authors:  K Saito; T S Nowak; S P Markey; M P Heyes
Journal:  J Neurochem       Date:  1993-01       Impact factor: 5.372

9.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

10.  MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon.

Authors:  A Suzumura; S G Mezitis; N K Gonatas; D H Silberberg
Journal:  J Neuroimmunol       Date:  1987 Jul-Aug       Impact factor: 3.478

View more
  18 in total

1.  Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid.

Authors:  J F Reinhard
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

2.  Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.

Authors:  M P Heyes; C Y Chen; E O Major; K Saito
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain.

Authors:  D Giulian; J Yu; X Li; D Tom; J Li; E Wendt; S N Lin; R Schwarcz; C Noonan
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

4.  Excitotoxicity of quinolinic acid: modulation by endogenous antagonists.

Authors:  K H Jhamandas; R J Boegman; R J Beninger; A F Miranda; K A Lipic
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 5.  Kynurenines in the CNS: recent advances and new questions.

Authors:  László Vécsei; Levente Szalárdy; Ferenc Fülöp; József Toldi
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

6.  Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

Authors:  M P Heyes; C L Achim; C A Wiley; E O Major; K Saito; S P Markey
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

7.  Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection.

Authors:  C N Venkateshan; R Narayanan; M G Espey; J R Moffett; D C Gajdusek; C J Gibbs; M A Namboodiri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

8.  Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy.

Authors:  Verena Eggers; Katja Fügener; Ortrud Vargas Hein; Hans Rommelspacher; Melvyn P Heyes; Wolfgang J Kox; Claudia D Spies
Journal:  Intensive Care Med       Date:  2004-04-27       Impact factor: 17.440

9.  Antibodies to quinolinic acid and the determination of its cellular distribution within the rat immune system.

Authors:  J R Moffett; M G Espey; M A Namboodiri
Journal:  Cell Tissue Res       Date:  1994-12       Impact factor: 5.249

Review 10.  The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.

Authors:  María Isabel Cuartero; Juan de la Parra; Alicia García-Culebras; Iván Ballesteros; Ignacio Lizasoain; María Ángeles Moro
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.